Skip to main content

Relias Media has upgraded our site!

Please bear with us as we work through some issues in order to provide you with a better experience.

Thank you for your patience.

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

<p>In this section: the FDA approves a nasal spray to cease or reverse opioid overdose, recommends stronger warning labels on fluoroquinolones, and greenlights a once-daily, fixed-dose combination pill for treating HIV-1 infection.</p>

FDA Actions